CHROMEDX SUBMITS PCT PATENT APPLICATION FOR HEMOPALMTM BLOOD ANALYSIS SYSTEM
TORONTO, ONTARIO -- (August 28, 2015) - ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (Frankfurt: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) technologies is pleased to ...
↧